For the past 14 years, I have studied various aspects of lung cancer biology, including invasion and metastasis, drug resistance, and the immune response. I received my Ph.D. in Cancer Biology from Emory University, and I studied the dynamic interplay between invasive subpopulations in lung cancer cells that promoted successful metastasis. From there, I completed my post-doctoral fellowship at MD Anderson. While I remained in the field of lung cancer, my post-doctoral research focused on drug resistance mechanisms, both to targeted therapies and to immune checkpoint inhibitors (ICI), to generate pre-clinical evidence for new combinatorial treatment strategies. My independent lab further dissects ICI therapy resistance mechanisms particularly in non-small cell lung cancer. We aim to study dynamic tumor:immune cell interactions to reveal targetable survival dependencies, thus preventing resistance. In particular, we examine the accumulation of certain bioactive metabolites within the tumor microenvironment that influence anti-tumor immunity.
Senior Scientist or Principal Investigator
Emory University, Atlanta, USA
01 Mar 2022 - present
Post Doctoral Researcher
The University of Texas MD Anderson Cancer Center, Houston, USA
01 Jan 2017 - 01 Mar 2022
Graduate Student or Post Graduate
Emory University, Atlanta, USA
01 Aug 2011 - 01 Dec 2016